OpGen logo

OpGen

North America, Maryland, United States, Rockville

Description

OpGen is a precision medicine company utilizing molecular diagnostics and bioinformatics to help combat infectious disease.

Investor Profile

OpGen has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OpGen frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 1

Which angels does OpGen often collaborate with?

BD
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by OpGen?

BioRelix

New Haven, Connecticut, United States

BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.

BiopharmaBiotechnologyPharmaceutical
Series UnknownMar 22, 2012
Amount Raised: $2,560,000